Minimally Invasive Treatment in Benign Prostatic Hyperplasia (BPH)

Area of Science:

• Urology
• Minimally Invasive Procedures
• Medical Technology

Background:

• Benign Prostatic Hyperplasia (BPH) is a common condition causing Lower Urinary Tract Symptoms (LUTS).
• Traditional surgical interventions, while effective, carry significant risks and side effects.
• There is a growing need for safer, less invasive treatment options for BPH patients.

Approach:

• A comprehensive systematic review of peer-reviewed literature published between 1993 and 2022.
• Inclusion of original research articles, reviews, and case studies from public repositories.
• Focus on evaluating the efficacy and safety profiles of various minimally invasive BPH treatments.

Key Points:

• Prostate Artery Embolization (PAE), Transurethral Needle Ablation (TUNA), Transurethral Microwave Thermotherapy (TUMT), High Intensity Focused Ultrasound (HIFU), laser treatments, and Cryoablation were assessed.
• These minimally invasive techniques demonstrate validity and safety in managing LUTS associated with BPH.
• Reported undesired effects are generally fewer compared to traditional surgical methods.

Conclusions:

• Minimally invasive treatments represent viable and safe alternatives to surgery for BPH-related LUTS.
• Patients may experience comparable symptom relief with an improved safety profile.
• Further research and clinical adoption of these techniques are warranted.